Evidence map›Paper›PMID 25248854›Full record

Trial reportBMC health services research2014

Intervention impact on depression product appraisal and purchasing behavior by employers: a randomized trial.

Kathryn M Rost, Donna Marshall, Stanley Xu

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC health services research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01013220 (Influencing Employer Purchasing Behavior), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01013220 nacompletednot on this map

Influencing Employer Purchasing Behavior

TypeinterventionalSponsorFlorida State UniversityRan2009 to 2014Enrolled293ConditionsDepressionArmsDepression Product Detailing, Depression HEDIS detailing
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Kathryn M RostDepartment of Mental Health Law and Policy, College of Behavioral and Community Studies, University of South Florida, 13301 Bruce B, Downs Boulevard, Tampa, FL 33612, USA. kmrost@usf.edu.
Donna Marshall
Stanley Xu
Colorado School of Public Health · USUniversity of South Florida · US

Funding

Influencing Employer Benefit Purchasing BehaviorR01MH076277 · NIMH · UNIVERSITY OF SOUTH FLORIDA · PI ROST, KATHRYN M · 2009 to 2013
$2.6M
NIMH NIH HHS MH76277NIMH NIH HHS R01 MH076277
6 · The paper itself

Abstract

backgroundEmployers can purchase high quality depression products that provide the type, intensity and duration of depression care management shown to improve work outcomes sufficiently for many employers to achieve a return on investment. The purpose of this randomized controlled trial was to test an intervention to encourage employers to purchase a high quality depression product for their workforce.

methodsTwenty nine organizations recruited senior health benefit professional members representing public or private employers who had not yet purchased a depression product for all 100+ workers in their company. The research team used randomization blocked by company size to assign eligible employers to: (1) a presentation encouraging employers to purchase a high quality depression product accompanied by a scientifically-derived return on investment estimate, or (2) a presentation encouraging employers to work with their most subscribed health plan to improve depression treatment quality indicators. Two hundred ninety three employers (82.3% of 356) completed baseline data immediately before learning that 140 employers had been randomized to the evidence-based (EB) depression product presentation and 153 had been randomized to the usual care (UC) depression treatment quality indicator presentation. Analysis of 250 (85.3% of 293) employers who completed web-based interviews at 12 and/or 24 months was conducted to determine presentation impact on depression product appraisal and purchasing behavior.

resultsThe intervention had no impact on depression product appraisal in 232 subjects (F = 2.36, p = .07) or depression product purchasing (chisquare = 1.82, p = .44) in 250 subjects. Depression product appraisal increased in companies with greater health benefit generosity whose benefit professionals were male. Depression product purchasing behavior increased in small companies compared to large companies, companies who knew a vendor that sold depression products at baseline, companies with greater health benefit risk taking, and companies with less politicalization of health care benefit decision making.

conclusionsPolicy makers need to build innovative bridges to the employer community to convince them to purchase evidence-based benefits, even when benefits offer potential financial savings.

trial registrationCLINICAL TRIALS REGISTRATION NUMBER: NCT01013220.

Indexed as

Decision Making, OrganizationalGroup PurchasingHealth Benefit Plans, EmployeeOccupational HealthAntidepressive AgentsDepressionHumansUnited StatesAntidepressive Agents

Identifiers

PMID25248854
PMCPMC4263121
OpenAlexW2131997628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.